SPL 2.11% 9.3¢ starpharma holdings limited

AZ drops midstage cancer drug vistusertibInteresting comment...

  1. 178 Posts.
    lightbulb Created with Sketch. 61

    AZ drops midstage cancer drug vistusertib

    Interesting comment from the article...

    "AZ’s chief medical officer Sean Bohen M.D., Ph.D., wouldn’t comment on the specific reasons for the decision on a call with reporters this morning but suggested it came about as a result of re-prioritization of the R&D portfolio. We’re in the fortunate position of having to choose between different programs within a very rich pipeline,” he said. “We have several factors to consider in making these choices, [including] the tolerability and efficacy, but also the evolution of treatment within a disease area.”

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.